Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Abroad (travel likely)RecruitingPHASE3

Conditions

Soft Tissue Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic Arizona, Phoenix, Arizona, United States
Contact: Study coordinator (Mahesh Seetharam, MD) · Seetharam.Mahesh@mayo.edu
Contact: Principal Investigator (Mahesh Seetharam, MD)
USC Norris comprehensive cancer center, Los Angeles, California, United States
Contact: Study coordinator (Mark Agulnik, M.D) · Mark.Agulnik@med.usc.edu · 323-865-3935
Contact: Principal Investigator (Mark Agulnik, M.D)
Stanford University Medical Centre, Palo Alto, California, United States
Contact: Study coordinator (Nam Bui, MD) · nambui@stanford.edu · 650-725-6413
Contact: Study coordinator (Kristen Ganjoo, MD) · kganjoo@stanford.edu · 650-725-6413
Contact: Principal Investigator (Nam Bui, MD)
UCSF, San Francisco, California, United States
Contact: Study coordinator (Varun Monga, M.D) · varun.monga@ucsf.edu · 415-514-7279
Contact: Principal Investigator (Varun Monga, M.D)
UCLA, Santa Monica, California, United States
Contact: Study coordinator (Arun Singh, M.D) · asingh@mednet.ucla.edu · 310-829-5471
Contact: Principal Investigator (Arun Singh, M.D)
University of Colorado Cancer Center/ CU Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Study coordinator (Breelyn Wilky, MD) · BREELYN.WILKY@cuanschutz.edu · 720-848-0300
Contact: Principal Investigator (Breelyn Wilky, MD)
Mayo Clinic Florida, Jacksonville, Florida, United States
Contact: Study coordinator (Steven Attia, DO) · Attia.Steven@mayo.edu
Contact: Principal Investigator (Steven Attia, DO)
University of Miami/ Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Contact: Study coordinator (Emily Jonczak, MD) · emily.jonczak@med.miami.edu · 305-243-2581
Contact: Principal Investigator (Emily Jonczak, MD)
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Study coordinator (Mihaela Druta, MD) · mihaela.druta@moffitt.org · 813-745-3242
Contact: Principal Investigator (Mihaela Druta, MD)
Northwestern, Chicago, Illinois, United States
Contact: Study coordinator (Seth Pollack, MD) · seth.pollack@northwestern.edu · 312-695-1300
Contact: Principal Investigator (Seth Pollack, MD)
Indiana University, Indianapolis, Indiana, United States
Contact: Study coordinator (Samantha Armstrong, MD) · saaarmst@iu.edu · 317-278-2686
Contact: Principal Investigator (Samantha Armstrong, MD)
University of Iowa, Iowa City, Iowa, United States
Mass General Brigham Cancer Center, Boston, Massachusetts, United States
Contact: Study coordinator (Edwin Choy, M.D) · echoy@mgh.harvard.edu · 617-724-4000
Contact: Principal Investigator (Edwin Choy, M.D)
University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Rashmi Chugh, MD) · rashmim@med.umich.edu · 734-936-0453
Contact: Principal Investigator (Rashmi Chugh, MD)
Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Brittany Siontis, M.D) · siontis.brittany@mayo.edu · 507-284-2511
Contact: Principal Investigator (Brittany Siontis, M.D)
Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
Contact: Study coordinator (Brian Van Tine, MD) · bvantine@wustl.edu · 3143627997
Contact: Principal Investigator (Brian Van Tine, MD)
NYU Langone Health, New York, New York, United States
Contact: Study coordinator (Matthew Ingham, MD) · Matthew.Ingham@nyulangone.org · 212-731-5324
Contact: Principal Investigator (Matthew Ingham, MD)
Columbia University, New York, New York, United States
Contact: Study coordinator (Igor Matushansky, M.D.Ph.D) · im17@cumc.columbia.edu · 917-757-8392
Contact: Principal Investigator (Igor Matushansky, M.D.Ph.D)
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Viswatej Avutu, MD) · avutuv@mskcc.org · 646-888-6860
Contact: Principal Investigator (Viswatej Avutu, MD)
Duke Cancer Institute, Durham, North Carolina, United States
Contact: Study coordinator (Juneko Grilley-Olson, MD) · juneko.grilleyolson@duke.edu · 919-668-6608
Contact: Principal Investigator (Juneko Grilley-Olson, MD)
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Study coordinator (Ankit Mangla, MD) · ankit.mangla@uhhospitals.org · 216-844-5715
Contact: Principal Investigator (Ankit Mangla, MD)
Ohio State University Wexner Medical Center/ The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States
Contact: Study coordinator (David Liebner, MD) · David.Liebner@osumc.edu · 614-366-6087
Contact: Principal Investigator (David Liebner, MD)
UPenn (Abramson Cancer Center, Pennsylvania Hospital), Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Lee Hartner, MD) · Lee.Hartner@pennmedicine.upenn.edu · 215-829-7089
Contact: Principal Investigator (Lee Hartner, MD)
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Melissa Burgess, M.D) · burgessma@upmc.edu · 412-692-4724
Contact: Principal Investigator (Melissa Burgess, M.D)
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (John A Livingston, MD) · jalivingston@mdanderson.org · 713-792-2848
Contact: Principal Investigator (John A Livingston, MD)
Medical College of Wisconsin/ Froedtert Hospital, Milwaukee, Wisconsin, United States
Contact: Study coordinator (John Charlson, MD) · jcharlso@mcw.edu · 414-805-0818
Contact: Principal Investigator (John Charlson, MD)
UHN - Princess Margaret Cancer Center (Ontario), Toronto, Ontario, Canada
Contact: Study coordinator (Albiruni Razak, MB BCh) · albiruni.razak@uhn.ca · 416-586-5371
Contact: Principal Investigator (Albiruni Razak, MB BCh)
McGill University Health Centre (Quebec), Montreal, Quebec, Canada
Contact: Study coordinator (Ramy Saleh, MD) · ramy.saleh@mcgill.ca · 514-934-1934
Contact: Principal Investigator (Ramy Saleh, MD)
Chang Gung Medical Foundation Kaohsiung, Kaohsiung City, Niaosong District, Taiwan
Contact: Study coordinator (Yu-Li Su, MD) · yolisu@cgmh.org.tw · 886 7 731 7123
Contact: Principal Investigator (Yu-Li Su, MD)
National Taiwan University Hospital, Taipei, Taipei, Taiwan
Contact: Study coordinator (Wei-Wu (Tom) Chen, MD) · tomwchen@ntuh.gov.tw · +886 2 2312 3456
Contact: Principal Investigator (Wei-Wu (Tom) Chen, MD)
Taipei Veterans General Hospital, Taipei, Taipei, Taiwan
Contact: Study coordinator (Chueh-Chuan Yen) · ccyen@vghtpe.gov.tw · +886 9 8176 4403
Contact: Principal Investigator (Chueh-Chuan Yen)

Study leads

John S Bomalaski
Study Director
Polaris Group

View source on ClinicalTrials.gov Contact study team (email)